Bacterial coinfections in COVID-19: an underestimated adversary.
Ann Ist Super Sanita
; 56(3): 359-364, 2020.
Article
in English
| MEDLINE | ID: covidwho-789696
ABSTRACT
Current literature shows that secondary bacterial infections, although less frequent than in previous influenza pandemics, affect COVID-19 patients. Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, Haemophilus and Klebsiella spp. are the main species isolated. Of note, Mycobacterium tuberculosis-COVID-19 coinfections are also reported. However, bacterial coinfection rates increase in patients admitted in the intensive care units, and those diseases can be due to super-infections by nosocomial antibiotic-resistant bacteria. This highlights the urgency to revise frequent and empiric prescription of broad-spectrum antibiotics in COVID-19 patients, with more attention to evidence-based studies and respect for the antimicrobial stewardship principles.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Bacterial Infections
/
Coronavirus Infections
/
Pandemics
/
Coinfection
/
Betacoronavirus
Type of study:
Diagnostic study
/
Observational study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Ann Ist Super Sanita
Year:
2020
Document Type:
Article
Affiliation country:
Ann_20_03_14
Similar
MEDLINE
...
LILACS
LIS